Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI
Absci Corporation, a data-first generative AI drug creation company, announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK), a leading cancer treatment and...
Lilly opens state-of-the-art research and development center in the Boston Seaport
Eli Lilly and Company announced the opening of the Lilly Seaport Innovation Center (LSC), a research and development facility in the Boston Seaport dedicated...
Daiichi Sankyo And MSD Expand Their ADC Partnership Globally
Daiichi Sankyo and MSD have widened their partnership to create and market three DXd-based antibody-drug conjugates (ADCs) all over the world.
DXd is the name...
Ideaya Acquires The B7H3/PTK7 BsADC Rights in $400M Deal
For an option on Biocytogen Pharmaceuticals’ possible first-in-class B7H3/PTK7 BsADC program, Ideaya Biosciences is paying more than $400 million. The goal of antibody drug...
Eli Lilly Secures Actinium-225 Supply Chain For Radiopharma
The largest pharmaceutical company in the world based on market value, Eli Lilly, is getting into the nuclear isotope manufacturing industry as cancer medicine...
Navigating Regulations For Emerging Life Sciences Therapies
The life sciences industry is going through a big change right now, thanks to the fast growth of new treatments like cell and gene...
Radiopharmaceutical Access Enhanced By New IAEA Database
Research, cooperation, and the sustainability of safe radiopharmaceuticals for clinical application will be aided by a new IAEA radiopharmacy database. To compile into the...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...